
Cineline India Q4 FY26 Results: PAT Rs 3 Cr, Revenue Rs 45 Crore
Updated: 18 May 2026 • 4:13 pm
Posted by:

Cineline India Q4 FY26 results were declared on May 15, 2026, at the board of directors meeting. Cineline India reported PAT of Rs 3 crore for the quarter ended March 31, 2026, up 50.0% YoY from Rs 2 crore in Q4 FY25, on revenue of Rs 45 crore. Cineline India is a cinema exhibition and entertainment company. Data sourced from BSE regulatory filing. Investors tracking Cineline India Q4 FY26 will find complete financial analysis, segment performance, and FY27 outlook in this article.
Click Here – Get Free Investment Predictions
Cineline India Q4 FY26 Financial Highlights
| Metric | Q4 FY26 | Comparison |
|---|---|---|
| PAT (Net Profit) | Rs 3 crore | up 50.0% YoY from Rs 2 crore in Q4 FY25 |
| Revenue from Operations | Rs 45 crore | Q4 FY26 (quarter ended March 31, 2026) |
| Ticker | CINELINE | Sector: Cinema |
Cineline India Q4 FY26 Performance Analysis
Cineline India Q4 FY26 results reflect the company’s operational performance during the January to March 2026 quarter. Cineline India operates in the cinema exhibition and entertainment space, a sector that has seen strong demand tailwinds in FY26 driven by domestic consumption growth, government capex, and India’s infrastructure buildout. The Q4 results cap the full FY26 year and set the baseline for FY27 guidance.
The quarter’s profitability improvement reflects better operating leverage, pricing discipline, and cost management. Investors tracking Cineline India Q4 FY26 will monitor FY27 revenue visibility and management commentary on margin sustainability. Track Cineline India on the Univest Screener for live data and analyst ratings.
Key Business Factors for Cineline India Q4 FY26
Sectoral Demand and Revenue Momentum
Cineline revenue of Rs 45 crore reflects the company’s ability to execute in a competitive cinema exhibition and entertainment environment. Q4 is typically the strongest quarter for most Indian companies as year-end government spending, project completions, and festival-driven demand peak. The company’s revenue base in the micro-cap segment reflects its niche positioning in cinema exhibition and entertainment.
Margin and Profitability Outlook
The company PAT of Rs 3.0 crore reflects profitable operations with improving margins across the business. EBITDA margin trends and operating leverage will be key metrics to watch as FY27 guidance is finalised.
FY27 Guidance and Business Outlook
Following the firm results, management commentary on FY27 revenue guidance, capital expenditure plans, dividend policy, and strategic priorities will be the key near-term catalysts for the stock. India’s robust GDP growth of 6.5%+ and the government’s sustained infrastructure and consumption push create a positive macro backdrop for FY27 across most sectors. Monitor Cineline India financials in real time on the Univest Screener.
Check the Univest Screener for live data
Download the Univest iOS App or Univest Android App to track live prices and SEBI-registered analyst research.
Frequently Asked Questions on Cineline
What is the company’s PAT?
Ans. Cineline reported PAT of Rs 3 crore up 50.0% YoY from Rs 2 crore in Q4 FY25. Results were declared on May 15, 2026. Full details are available from NSE/BSE regulatory filings. Verify all numbers before investing.
What is the company’s revenue?
Ans. The firm’s revenue from operations was Rs 45 crore for the quarter ended March 31, 2026. Track real-time financials on the Univest Screener.
When were Cineline results announced?
Ans. The company results were announced on May 15, 2026, at the board of directors meeting approving audited financial statements for Q4 and the full year ended March 31, 2026.
What sector does Cineline India operate in?
Ans. Cineline India operates in the cinema exhibition and entertainment sector. Download the Univest iOS App or Univest Android App to track Cineline India and get SEBI-registered research.
Is Cineline India a good investment after Q4 FY26?
Ans. Investment decisions should be based on comprehensive analysis of fundamentals, sector dynamics, valuation, and individual risk appetite. This article does not constitute investment advice. Consult a SEBI-registered financial advisor before investing. This content is for educational purposes only.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Recent Posts
Alembic Pharmaceuticals Q4 FY26 Results: PAT Rs 202 Cr, Revenue Rs 1,848 Crore
Omaxe Q4 FY26 Results: Loss Rs 191 Cr, Revenue Rs 349 Crore
Reliance Power Analyst Review May 2026
Hindustan Organic Chemicals Q4 FY26 Results: PAT Rs 16 Cr, Revenue Rs 136 Crore
GIC Housing Finance Q4 FY26 Results: PAT Rs 54 Cr, Revenue Rs 273 Crore
Popular this week
Alembic Pharmaceuticals Q4 FY26 Results: PAT Rs 202 Cr, Revenue Rs 1,848 Crore
Omaxe Q4 FY26 Results: Loss Rs 191 Cr, Revenue Rs 349 Crore
Reliance Power Analyst Review May 2026
Hindustan Organic Chemicals Q4 FY26 Results: PAT Rs 16 Cr, Revenue Rs 136 Crore
GIC Housing Finance Q4 FY26 Results: PAT Rs 54 Cr, Revenue Rs 273 Crore

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
